-
1
-
-
0031804584
-
Current drug treatment strategies for disseminated intravascular coagulation
-
de Jonge E, Levi M, Stoutenbeek C, van Deventer SJ. Current Drug Treatment Strategies for Disseminated Intravascular Coagulation. Drugs 1998;55:767-77.
-
(1998)
Drugs
, vol.55
, pp. 767-777
-
-
De Jonge, E.1
Levi, M.2
Stoutenbeek, C.3
Van Deventer, S.J.4
-
2
-
-
33746335005
-
Recent acquisition in the pathophysiology, diagnosis, and treatment of disseminated intravascular coagulation
-
Lippi G, Franchini M, Manzato F. Recent acquisition in the pathophysiology, diagnosis, and treatment of disseminated intravascular coagulation. Thrombosis J 2006;4:4.
-
(2006)
Thrombosis J
, vol.4
, pp. 4
-
-
Lippi, G.1
Franchini, M.2
Manzato, F.3
-
3
-
-
0142185079
-
Disseminated intravascular coagulation: Old disease, new hope
-
Toh, CH, Dennis M. Disseminated intravascular coagulation: Old disease, new hope. BMJ 2003;237:974-7.
-
(2003)
BMJ
, vol.237
, pp. 974-977
-
-
Toh, C.H.1
Dennis, M.2
-
4
-
-
2542542737
-
Update on the treatment of disseminated intravascular coagulation
-
Franchini M, Manzato F. Update on the Treatment of Disseminated Intravascular Coagulation. Hematology 2004:9:81-5.
-
(2004)
Hematology
, vol.9
, pp. 81-85
-
-
Franchini, M.1
Manzato, F.2
-
5
-
-
0033810384
-
Novel approaches to the management of disseminated intravascular coagulation
-
Levi M, de Jonge E, van der Poll T, ten Cate H. Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med 2000;28(9 Suppl):S20-4.
-
(2000)
Crit Care Med
, vol.28
, Issue.9 SUPPL.
-
-
Levi, M.1
De Jonge, E.2
Van Der Poll, T.3
Ten Cate, H.4
-
6
-
-
0037206588
-
Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases
-
Mueller M, Bomke B, Siefried E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thrombosis Res 2002;107:S9-17.
-
(2002)
Thrombosis Res
, vol.107
-
-
Mueller, M.1
Bomke, B.2
Siefried, E.3
-
7
-
-
0032889533
-
Effects of low molecular weight heparin, alone or combined with antithrombin III on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits
-
Hermida J, Montes R, Munoz MC, Orbe J, Paramo JA, Rocha E. Effects of Low Molecular Weight Heparin, Alone or Combined with Antithrombin III on Mortality, Fibrin Deposits and Hemostatic Parameters in Endotoxin-Induced Disseminated Intravascular Coagulation in Rabbits. Am J Hematol 1999;60:6-11.
-
(1999)
Am J Hematol
, vol.60
, pp. 6-11
-
-
Hermida, J.1
Montes, R.2
Munoz, M.C.3
Orbe, J.4
Paramo, J.A.5
Rocha, E.6
-
8
-
-
33747035271
-
Antithrombin III and recombinant tissue plasminogen activator used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation in the neonatal pig
-
Davis-Jackson R, Correa H, Horswall R, Sadowska-Krowicka H, McDonough K, Debata C, et al. Antithrombin III and recombinant tissue plasminogen activator used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation in the neonatal pig. Thrombosis J 2006;4:7.
-
(2006)
Thrombosis J
, vol.4
, pp. 7
-
-
Davis-Jackson, R.1
Correa, H.2
Horswall, R.3
Sadowska-Krowicka, H.4
McDonough, K.5
Debata, C.6
|